Richard Stidolph

Richard Stidolph is an accomplished regulatory CMC professional with extensive experience in the pharmaceutical industry. Currently serving as Director of Regulatory CMC at Liminal BioSciences since January 2021, Richard previously held roles at PAION UK LIMITED as Associate Director CMC / Regulatory and Regulatory CMC Manager at Mylan. Their expertise encompasses the authoring of critical regulatory documentation, managing CMC activities at Contract Manufacturing Organisations, and leading a team in compliance with global regulatory standards. Richard's early career also included responsibilities focused on API sourcing and regulatory support for various international markets. Richard holds an MChem degree in Chemistry from The University of Manchester.